Article Information
History
- March 16, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Robert J Massey1,
- Yu Chen2,
- Marina Panova-Noeva3,
- Michaela Mattheus3,
- Moneeza K Siddiqui1,4,
- Nanette C Schloot5,
- Antonio Ceriello6,
- Ewan R Pearson1 and
- Adem Y Dawed1,*
- 1Population Health & Genomics, University of Dundee, UK
- 2Lilly Research Laboratories, Eli Lilly and Company, IN, USA
- 3Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
- 4Centre for Primary Care, Wolfson Institute of Population Health, Queen Mary University of London
- 5Lilly Deutschland GmbH, Bad Homburg, Germany
- 6IRCCS MultiMedica, Via Milanese 300, 20099 Sesto San Giovanni, MI, Italy
- ↵*Address for correspondence: Adem Yusef Dawed, Division of Population Health and Genomics, School of Medicine, University of Dundee, DD1 9SY, UK; Email: aydawed{at}dundee.ac.uk, Tel: +44 1382 386715
Posted March 16, 2024.
BMI Variability and Cardiovascular Outcomes Within Clinical Trial and Real-World Environments in Type 2 Diabetes: An IMI2 SOPHIA study
